StonvexLoading…
StonvexStonvexStonvexCore line items from ASAN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2026 2026-01-31 | Annual 2025 2025-01-31 | Annual 2024 2024-01-31 | Annual 2023 2023-01-31 |
|---|---|---|---|---|
Revenue | $790.81M | $723.88M | $652.50M | $547.21M |
Operating Income | $-197.33M | $-266.74M | $-270.00M | $-407.83M |
Net Income | $-189.02M | $-255.54M | $-257.03M | $-407.77M |
EPS (Diluted) | $-0.80 | $-1.11 | $-1.17 | $-2.04 |
Total Assets | $844.09M | $891.41M | $961.96M | $954.96M |
Total Liabilities | $689.97M | $663.89M | $635.56M | $598.39M |
Cash & Equivalents | $199.84M | $184.73M | $236.66M | $526.56M |
Free Cash Flow OCF − CapEx | $86.57M | $9.36M | $-25.65M | $-165.41M |
Shares Outstanding | 236.82M | 229.47M | 224.73M | 214.29M |